# An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects

> **NCT02116907** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 7 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** E2007

## Key facts

- **NCT ID:** NCT02116907
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02116907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02116907, "An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02116907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*